Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) Tablet
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and tolerance by comparing pharmacokinetic
characteristics between the CKD-4101 tablet and Mycophenolate mofetil capsule when
administered alone to healthy volunteers.